The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Evidence for Cardiomyocyte Renewal in Humans
Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabé-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., et al. (2009) · Science · doi:10.1126/science.1164680 · Cited by 3,130
Targeting the phosphoinositide 3-kinase pathway in cancer
Liu, P., Cheng, H., Roberts, T. M., & Zhao, J. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2926 · Cited by 2,721
Targeting cancer with small molecule kinase inhibitors
Zhang, J., Yang, P. L., & Gray, N. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2559 · Cited by 2,576
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050
A small molecule–kinase interaction map for clinical kinase inhibitors
Fabian, M. A., Biggs, W. H., Treiber, D. K., Atteridge, C. E., Azimioara, M. D., Benedetti, M. G., Carter, T. A., Ciceri, P., Edeen, P. T., Floyd, M., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1068 · Cited by 1,892
Itskovitz-Eldor, J., Schuldiner, M., Karsenti, D., Eden, A., Yanuka, O., Amit, M., Soreq, H., & Benvenisty, N. (2000) · Molecular Medicine · doi:10.1007/bf03401776 · Cited by 1,500
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Zebrafish as a Model Vertebrate for Investigating Chemical Toxicity
Hill, A. J., Teraoka, H., Heideman, W., & Peterson, R. E. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi110 · Cited by 1,374
Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation
Jopling, C., Sleep, E., Raya, M., Martí, M., Raya, A., & Belmonte, J. C. I. (2010) · Nature · doi:10.1038/nature08899 · Cited by 1,333
Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
Kerkelä, R., Grazette, L., Yacobi, R., Iliescu, C., Patten, R., Beahm, C., Walters, B., Shevtsov, S., Pesant, S., Clubb, F. J., et al. (2006) · Nature Medicine · doi:10.1038/nm1446 · Cited by 1,159
Self-citationCardiotoxicity associated with tyrosine kinase inhibitor sunitinib
Chu, T. F., Rupnick, M. A., Kerkela, R., Dallabrida, S. M., Zurakowski, D., Nguyen, L., Woulfe, K., Pravda, E., Cassiola, F., Desai, J., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61865-0 · Cited by 1,083
Self-citationReversal of experimental pulmonary hypertension by PDGF inhibition
Schermuly, R. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24838 · Cited by 1,058
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Cardinale, D., Colombo, A., Sandri, M. T., Lamantia, G., Colombo, N., Civelli, M., Martinelli, G., Veglia, F., Fiorentini, C., & Cipolla, C. M. (2006) · Circulation · doi:10.1161/circulationaha.106.635144 · Cited by 1,026
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
Sebolt-Leopold, J. S., Dudley, D. T., Herrera, R., Becelaere, K. V., Wiland, A., Gowan, R. C., Tecle, H., Barrett, S. D., Bridges, A., Przybranowski, S., et al. (1999) · Nature Medicine · doi:10.1038/10533 · Cited by 970
p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload
Sano, M., Minamino, T., Toko, H., Miyauchi, H., Orimo, M., Qin, Y., Akazawa, H., Tateno, K., Kayama, Y., Harada, M., et al. (2007) · Nature · doi:10.1038/nature05602 · Cited by 905
Cell cycle kinases as therapeutic targets for cancer
Lapenna, S., & Giordano, A. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2907 · Cited by 905
ErbB2 is essential in the prevention of dilated cardiomyopathy
Crone, S. A., Zhao, Y.-Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-459 · Cited by 903
Electromechanical integration of cardiomyocytes derived from human embryonic stem cells
Kehat, I., Khimovich, L., Caspi, O., Gepstein, A., Shofti, R., Arbel, G., Huber, I., Satin, J., Itskovitz-Eldor, J., & Gepstein, L. (2004) · Nature Biotechnology · doi:10.1038/nbt1014 · Cited by 880
Matsui, T., Tao, J., del Monte, F., Lee, K.-H., Li, L., Picard, M., Force, T. L., Franke, T. F., Hajjar, R. J., & Rosenzweig, A. (2001) · Circulation · doi:10.1161/01.cir.104.3.330 · Cited by 701
Self-citationCalcium Pumps in Health and Disease
Brini, M., & Carafoli, E. (2009) · Physiological Reviews · doi:10.1152/physrev.00032.2008 · Cited by 676
Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
Cardinale, D., Colombo, A., Torrisi, R., Sandri, M. T., Civelli, M., Salvatici, M., Lamantia, G., Colombo, N., Cortinovis, S., Dessanai, M. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.3615 · Cited by 641
Cohen, P. (2001) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02473.x · Cited by 634
Marroquin, L. D., Hynes, J., Dykens, J. A., Jamieson, J. D., & Will, Y. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm052 · Cited by 628
Ohren, J. F., Chen, H., Pavlovsky, A., Whitehead, C., Zhang, E., Kuffa, P., Yan, C., McConnell, P., Spessard, C., Banotai, C., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb859 · Cited by 626
Hypoxia-induced energy stress regulates mRNA translation and cell growth
Liu, L., Cash, T. P., Jones, R. G., Keith, B., Thompson, C. B., & Simon, M. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.010 · Cited by 607
Properties of a clonal muscle cell line from rat heart
KIMES, B., & BRANDT, B. (1976) · Experimental Cell Research · doi:10.1016/0014-4827(76)90447-x · Cited by 594
Akt1 Is Required for Physiological Cardiac Growth
DeBosch, B., Treskov, I., Lupu, T. S., Weinheimer, C., Kovacs, A., Courtois, M., & Muslin, A. J. (2006) · Circulation · doi:10.1161/circulationaha.105.595231 · Cited by 535
Blair, E. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.11.1215 · Cited by 528
Hescheler, J., Meyer, R., Plant, S., Krautwurst, D., Rosenthal, W., & Schultz, G. (1991) · Circulation Research · doi:10.1161/01.res.69.6.1476 · Cited by 518
Fazel, S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27019 · Cited by 517
Essential Role of p38α MAP Kinase in Placental but Not Embryonic Cardiovascular Development
Adams, R. H., Porras, A., Alonso, G., Jones, M., Vintersten, K., Panelli, S., Valladares, A., Perez, L., Klein, R., & Nebreda, A. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00014-6 · Cited by 516
The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease
OUDIT, G. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.015 · Cited by 469
Simpson, P., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.50.1.101 · Cited by 453
A New Season for Cardiac Troponin Assays: It’s Time to Keep a Scorecard
Apple, F. S. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2009.128363 · Cited by 438
Metabolic signatures of exercise in human plasma
Lewis, G. D., Farrell, L., Wood, M. J., Martinovic, M., Arany, Z., Rowe, G. C., Souza, A., Cheng, S., McCabe, E. L., Yang, E., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001006 · Cited by 432
Simpson, P., McGrath, A., & Savion, S. (1982) · Circulation Research · doi:10.1161/01.res.51.6.787 · Cited by 426
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
Noma, T., Lemaire, A., Naga Prasad, S. V., Barki-Harrington, L., Tilley, D. G., Chen, J., Le Corvoisier, P., Violin, J. D., Wei, H., Lefkowitz, R. J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31901 · Cited by 418
Eschenhagen, T., Force, T., Ewer, M. S., de Keulenaer, G. W., Suter, T. M., Anker, S. D., Avkiran, M., de Azambuja, E., Balligand, J.-L., Brutsaert, D. L., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq213 · Cited by 413
Self-citationWhite, S. M., Constantin, P. E., & Claycomb, W. C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00986.2003 · Cited by 410
Rini, B. I., Michaelson, M. D., Rosenberg, J. E., Bukowski, R. M., Sosman, J. A., Stadler, W. M., Hutson, T. E., Margolin, K., Harmon, C. S., DePrimo, S. E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5416 · Cited by 393
Cardiac Safety of Lapatinib: Pooled Analysis of 3689 Patients Enrolled in Clinical Trials
Perez, E. A., Koehler, M., Byrne, J., Preston, A. J., Rappold, E., & Ewer, M. S. (2008) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60896-3 · Cited by 388
Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
Ghofrani, H. A., Morrell, N. W., Hoeper, M. M., Olschewski, H., Peacock, A. J., Barst, R. J., Shapiro, S., Golpon, H., Toshner, M., Grimminger, F., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0123oc · Cited by 384
Ling, H., Zhang, T., Pereira, L., Means, C. K., Cheng, H., Gu, Y., Dalton, N. D., Peterson, K. L., Chen, J., Bers, D., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38022 · Cited by 383
Guazzi, M., Vicenzi, M., Arena, R., & Guazzi, M. D. (2011) · Circulation: Heart Failure · doi:10.1161/circheartfailure.110.944694 · Cited by 382
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Braam, S. R., Tertoolen, L., van de Stolpe, A., Meyer, T., Passier, R., & Mummery, C. L. (2010) · Stem Cell Research · doi:10.1016/j.scr.2009.11.004 · Cited by 368
The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders
Aoki, Y., Niihori, T., Narumi, Y., Kure, S., & Matsubara, Y. (2008) · Human Mutation · doi:10.1002/humu.20748 · Cited by 365
Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function
Iwamoto, R., Yamazaki, S., Asakura, M., Takashima, S., Hasuwa, H., Miyado, K., Adachi, S., Kitakaze, M., Hashimoto, K., Raab, G., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0537588100 · Cited by 341
Novel cell lines derived from adult human ventricular cardiomyocytes
DAVIDSON, M., NESTI, C., PALENZUELA, L., WALKER, W., HERNANDEZ, E., PROTAS, L., HIRANO, M., & ISAAC, N. (2005) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2005.03.003 · Cited by 327
Izumiya, Y., Shiojima, I., Sato, K., Sawyer, D. B., Colucci, W. S., & Walsh, K. (2006) · Hypertension · doi:10.1161/01.hyp.0000215207.54689.31 · Cited by 326
Molecular regulation of cardiac hypertrophy
Barry, S. P., Davidson, S. M., & Townsend, P. A. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.02.020 · Cited by 306
McMullen, J. R., Amirahmadi, F., Woodcock, E. A., Schinke-Braun, M., Bouwman, R. D., Hewitt, K. A., Mollica, J. P., Zhang, L., Zhang, Y., Shioi, T., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606663104 · Cited by 299
Selectively Nonselective Kinase Inhibition: Striking the Right Balance
Morphy, R. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901132v · Cited by 292
A decade of discoveries in cardiac biology
Olson, E. N. (2004) · Nature Medicine · doi:10.1038/nm0504-467 · Cited by 291
Cardiotoxicity induced by tyrosine kinase inhibitors
Orphanos, G. S., Ioannidis, G. N., & Ardavanis, A. G. (2009) · Acta Oncologica · doi:10.1080/02841860903229124 · Cited by 284
Kunisada, K., Negoro, S., Tone, E., Funamoto, M., Osugi, T., Yamada, S., Okabe, M., Kishimoto, T., & Yamauchi-Takihara, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.315 · Cited by 273
Atrial Natriuretic Factor-SV40 T Antigen Transgenes Produce Tumors and Cardiac Arrhythmias in Mice
Field, L. J. (1988) · Science · doi:10.1126/science.2964082 · Cited by 270
De Angelis, A., Piegari, E., Cappetta, D., Marino, L., Filippelli, A., Berrino, L., Ferreira-Martins, J., Zheng, H., Hosoda, T., Rota, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.895771 · Cited by 268
Henderson, I. C., Allegra, J. C., Woodcock, T. M., Wolff, S., Bryan, S., Cartwright, K. J., Dukart, G., & Henry, D. W. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.5.560 · Cited by 246
Kerkela, R., Woulfe, K. C., Durand, J., Vagnozzi, R., Kramer, D., Chu, T. F., Beahm, C., Chen, M. H., & Force, T. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00090.x · Cited by 242
Self-citationSelectivity and therapeutic inhibition of kinases: to be or not to be?
Ghoreschi, K., Laurence, A., & O'Shea, J. J. (2009) · Nature Immunology · doi:10.1038/ni.1701 · Cited by 241
Pim-1 regulates cardiomyocyte survival downstream of Akt
Muraski, J. A., Rota, M., Misao, Y., Fransioli, J., Cottage, C., Gude, N., Esposito, G., Delucchi, F., Arcarese, M., Alvarez, R., et al. (2007) · Nature Medicine · doi:10.1038/nm1671 · Cited by 239
Kerkela, R., Kockeritz, L., MacAulay, K., Zhou, J., Doble, B. W., Beahm, C., Greytak, S., Woulfe, K., Trivedi, C. M., Woodgett, J. R., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36245 · Cited by 235
Self-citationMEK1-ERK2 Signaling Pathway Protects Myocardium From Ischemic Injury In Vivo
Lips, D. J., Bueno, O. F., Wilkins, B. J., Purcell, N. H., Kaiser, R. A., Lorenz, J. N., Voisin, L., Saba-El-Leil, M. K., Meloche, S., Pouysségur, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127126.73759.23 · Cited by 233
KHOURI, E. M., GREGG, D. E., & RAYFORD, C. R. (1965) · Circulation Research · doi:10.1161/01.res.17.5.427 · Cited by 229
Application of Metabolomics to Cardiovascular Biomarker and Pathway Discovery
Lewis, G. D., Asnani, A., & Gerszten, R. E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.043 · Cited by 227
Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling
Yamaguchi, O., Higuchi, Y., Hirotani, S., Kashiwase, K., Nakayama, H., Hikoso, S., Takeda, T., Watanabe, T., Asahi, M., Taniike, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136717100 · Cited by 224
A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy
Lorenz, K., Schmitt, J. P., Schmitteckert, E. M., & Lohse, M. J. (2009) · Nature Medicine · doi:10.1038/nm.1893 · Cited by 220
Padin-Iruegas, M. E., Misao, Y., Davis, M. E., Segers, V. F. M., Esposito, G., Tokunou, T., Urbanek, K., Hosoda, T., Rota, M., Anversa, P., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.852285 · Cited by 217
Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice
Louvet, C., Szot, G. L., Lang, J., Lee, M. R., Martinier, N., Bollag, G., Zhu, S., Weiss, A., & Bluestone, J. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810246105 · Cited by 217
Defective “pacemaker” current ( I h ) in a zebrafish mutant with a slow heart rate
Baker, K., Warren, K. S., Yellen, G., & Fishman, M. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4554 · Cited by 215
Will, Y., Dykens, J. A., Nadanaciva, S., Hirakawa, B., Jamieson, J., Marroquin, L. D., Hynes, J., Patyna, S., & Jessen, B. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn157 · Cited by 205
Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis
Yamaguchi, O., Watanabe, T., Nishida, K., Kashiwase, K., Higuchi, Y., Takeda, T., Hikoso, S., Hirotani, S., Asahi, M., Taniike, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420317 · Cited by 204
Huang, C., Zhang, X., Ramil, J. M., Rikka, S., Kim, L., Lee, Y., Gude, N. A., Thistlethwaite, P. A., Sussman, M. A., Gottlieb, R. A., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.902221 · Cited by 203
Zhang, T., Kohlhaas, M., Backs, J., Mishra, S., Phillips, W., Dybkova, N., Chang, S., Ling, H., Bers, D. M., Maier, L. S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707083200 · Cited by 201
De Keulenaer, G. W., Doggen, K., & Lemmens, K. (2010) · Circulation Research · doi:10.1161/circresaha.109.205906 · Cited by 201
Takimoto, E., Koitabashi, N., Hsu, S., Ketner, E. A., Zhang, M., Nagayama, T., Bedja, D., Gabrielson, K. L., Blanton, R., Siderovski, D. P., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci35620 · Cited by 200
Zhang, Y., Bo, J., Taffet, G. E., Chang, J., Shi, J., Reddy, A. K., Michael, L. H., Schneider, M. D., Entman, M. L., Schwartz, R. J., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5129com · Cited by 200
Gelb, B. D., & Tartaglia, M. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl197 · Cited by 198
Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog
Swain, J. L., Sabina, R. L., McHale, P. A., Greenfield, J. C., & Holmes, E. W. (1982) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1982.242.5.h818 · Cited by 196
Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia
Mora, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg469 · Cited by 196
Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics
Cheng, H., & Force, T. (2010) · Circulation Research · doi:10.1161/circresaha.109.206920 · Cited by 192
Self-citationSag, C. M., Wadsack, D. P., Khabbazzadeh, S., Abesser, M., Grefe, C., Neumann, K., Opiela, M.-K., Backs, J., Olson, E. N., Brown, J. H., et al. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.109.865279 · Cited by 191
Chintalgattu, V., Ai, D., Langley, R. R., Zhang, J., Bankson, J. A., Shih, T. L., Reddy, A. K., Coombes, K. R., Daher, I. N., Pati, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39434 · Cited by 188
Zhang, P., Hu, X., Xu, X., Fassett, J., Zhu, G., Viollet, B., Xu, W., Wiczer, B., Bernlohr, D. A., Bache, R. J., et al. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114702 · Cited by 187
mTOR pathway as a target in tissue hypertrophy
Lee, C.-H., Inoki, K., & Guan, K.-L. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105359 · Cited by 179
Harris, I. S., Zhang, S., Treskov, I., Kovacs, A., Weinheimer, C., & Muslin, A. J. (2004) · Circulation · doi:10.1161/01.cir.0000138190.50127.6a · Cited by 177
Calcium Handling in Human Embryonic Stem Cell-Derived Cardiomyocytes
Satin, J., Itzhaki, I., Rapoport, S., Schroder, E. A., Izu, L., Arbel, G., Beyar, R., Balke, C. W., Schiller, J., & Gepstein, L. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0591 · Cited by 175
Lin, R. C. Y., Weeks, K. L., Gao, X.-M., Williams, R. B. H., Bernardo, B. C., Kiriazis, H., Matthews, V. B., Woodcock, E. A., Bouwman, R. D., Mollica, J. P., et al. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.201988 · Cited by 170
The mTOR Pathway: A New Target in Cancer Therapy
Ciuffreda, L., Di Sanza, C., Incani, U. C., & Milella, M. (2010) · Current Cancer Drug Targets · doi:10.2174/156800910791517172 · Cited by 170
Peng, X. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24497 · Cited by 166
Hypertension as a predictive factor of Sunitinib activity
Rixe, O., Billemont, B., & Izzedine, H. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm184 · Cited by 166
Role of the JAK–STAT pathway in myocardial injury
Barry, S. P., Townsend, P. A., Latchman, D. S., & Stephanou, A. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.12.002 · Cited by 165
Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction
Ikeda, Y., Sato, K., Pimentel, D. R., Sam, F., Shaw, R. J., Dyck, J. R. B., & Walsh, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057273 · Cited by 164
Akt2 Regulates Cardiac Metabolism and Cardiomyocyte Survival
DeBosch, B., Sambandam, N., Weinheimer, C., Courtois, M., & Muslin, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513087200 · Cited by 164
Phosphoinositide 3-Kinase γ–Deficient Mice Are Protected From Isoproterenol-Induced Heart Failure
Oudit, G. Y., Crackower, M. A., Eriksson, U., Sarao, R., Kozieradzki, I., Sasaki, T., Irie-Sasaki, J., Gidrewicz, D., Rybin, V. O., Wada, T., et al. (2003) · Circulation · doi:10.1161/01.cir.0000091403.62293.2b · Cited by 159
An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic
Fernández, A., Sanguino, A., Peng, Z., Ozturk, E., Chen, J., Crespo, A., Wulf, S., Shavrin, A., Qin, C., Ma, J., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32373 · Cited by 158
Klein, M., SCHERMULY, R. T., Ellinghaus, P., Milting, H., Riedl, B., Nikolova, S., Pullamsetti, S. S., Weißmann, N., Dony, E., Savai, R., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.779751 · Cited by 156
Agostino, N. M., Chinchilli, V. M., Lynch, C. J., Koszyk-Szewczyk, A., Gingrich, R., Sivik, J. M., & Drabick, J. J. (2010) · Journal of Oncology Pharmacy Practice · doi:10.1177/1078155210378913 · Cited by 156
A General Strategy for Creating “Inactive-Conformation” Abl Inhibitors
Barun, O., Nagle, A. S., Adrián, F., Lee, C. R., Ren, P., Wang, X., Sim, T., Xie, Y., Wang, X., Xia, G., et al. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.015 · Cited by 147
Protein Kinase Cα, but Not PKCβ or PKCγ, Regulates Contractility and Heart Failure Susceptibility
Liu, Q., Chen, X., MacDonnell, S. M., Kranias, E. G., Lorenz, J. N., Leitges, M., Houser, S. R., & Molkentin, J. D. (2009) · Circulation Research · doi:10.1161/circresaha.109.195313 · Cited by 143
Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle
Rivello, H. G., Taranda, J., Said, M., Meckert, P. M. C., Petroff, M. V., Scaglione, J., Ghio, S., Chen, J., Lai, C., Laguens, R. P., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00048.2005 · Cited by 143
The use of in vivo zebrafish assays in drug toxicity screening
Eimon, P. M., & Rubinstein, A. L. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250902882128 · Cited by 138
Distinct roles of GSK-3α and GSK-3β phosphorylation in the heart under pressure overload
Matsuda, T., Zhai, P., Maejima, Y., Hong, C., Gao, S., Tian, B., Goto, K., Takagi, H., Tamamori‐Adachi, M., Kitajima, S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808315106 · Cited by 138
Extracellular signal‐regulated kinase 1/2 (ERK1/2) signaling in cardiac hypertrophy
Kehat, I., & Molkentin, J. D. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05088.x · Cited by 136
Functional properties of K+ currents in adult mouse ventricular myocytes
Brouillette, J., Clark, R. B., Giles, W. R., et al. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063446 · Cited by 130
Mice thrive without Cdk4 and Cdk2
Barrière, C., Santamaría, D., Cerqueira, A., Galán, J., Martín, A., Ortega, S., Malumbres, M., Dubus, P. R., & Barbacid, M. (2007) · Molecular Oncology · doi:10.1016/j.molonc.2007.03.001 · Cited by 130
Hasinoff, B. B., Patel, D., & O’Hara, K. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050104 · Cited by 126
Mediating ERK1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome
Nakamura, T., Colbert, M. C., Krenz, M., Molkentin, J. D., Hahn, H. S., Dorn, G. W., & Robbins, J. M. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30756 · Cited by 124
Blair, E. M., Redwood, C. S., Ashrafian, H., Oliveira, S. M., Broxholme, J., Kerr, B. A., Salmon, A. P., Östman‐Smith, I., & Watkins, H. C. (2001) · Journal of Medical Genetics · Cited by 124
Exposure to Anthracyclines During Childhood Causes Cardiac Injury
Lipshultz, S. E. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2006.04.019 · Cited by 120
Research Priorities in Hypertrophic Cardiomyopathy
Force, T. L., Bonow, R. O., Houser, S. R., Solaro, R. J., Hershberger, R. E., Adhikari, B. B., Anderson, M. E., Boineau, R., Byrne, B. J., Cappola, T. P., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.950089 · Cited by 120
Self-citationViđarsson, H., Hyllner, J., & Sartipy, P. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9113-x · Cited by 118
Woulfe, K. C., Gao, E., Lal, H., Harris, D., Fan, Q. N., Vagnozzi, R. J., DeCaul, M., Shang, X., Patel, S., Woodgett, J. R., et al. (2010) · Circulation Research · doi:10.1161/circresaha.109.211482 · Cited by 118
Self-citationHypertension and clinical benefit of bevacizumab in the treatment of advanced renal cell carcinoma
Bono, P., Elfving, H., Utriainen, T., Osterlund, P. J., Saarto, T., Alanko, T., & Joensuu, H. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn729 · Cited by 117
Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics
Chopra, P., Sethi, G., Dastidar, S. G., & Ray, A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903483191 · Cited by 116
Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failure
Liu, F.-F., Stone, J. R., Schuldt, A. J. T., Okoshi, K., Okoshi, M. P., Nakayama, M., Ho, K. K. L., Manning, W. J., Marchionni, M. A., Lorell, B. H., et al. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00268.2005 · Cited by 116
Ayach, B., Yoshimitsu, M., Dawood, F., Sun, M., Arab, S., Chen, M., Higuchi, K., Siatskas, C., Lee, P. C., Lim, H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510997103 · Cited by 115
Longevity of adult ventricular rat heart muscle cells in serum-free primary culture
Volz, A. (1991) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(91)90103-s · Cited by 114
New Developments in Anthracycline-Induced Cardiotoxicity
Mordente, A., Meucci, E., Silvestrini, A., Martorana, G. E., & Giardina, B. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788186228 · Cited by 112
Lymperopoulos, A., Rengo, G., Gao, E., Ebert, S. N., Dorn, G. W., & Koch, W. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077859 · Cited by 111
Zhang, T., Guo, T., Mishra, S., Dalton, N. D., Kranias, E. G., Peterson, K. L., Bers, D. M., & Brown, J. H. (2009) · Circulation Research · doi:10.1161/circresaha.109.207423 · Cited by 108
Deng, X.-F., Rokosh, G. D., & Simpson, P. C. (2000) · Circulation Research · doi:10.1161/01.res.87.9.781 · Cited by 106
Adult rat ventricular myocytes cultured in defined medium: phenotype and electromechanical function
Ellingsen, Ø., Davidoff, A. J., Prasad, S. K., Berger, H. J. C., Springhorn, J. P., Marsh, J. D., Kelly, R. A., & Smith, T. W. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.2.h747 · Cited by 105
Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity.
Herman, E., & Ferrans, V. J. (1998) · PubMed · Cited by 104
Kondo, R. P., Dederko, D. A., Teutsch, C., Chrast, J., Catalucci, D., Chien, K. R., & Giles, W. R. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.101428 · Cited by 104
Molkentin, J. D., & Robbins, J. M. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.09.002 · Cited by 104
Cardiac stem cells and myocardial disease
Kajstura, J., Urbanek, K., Rota, M., Bearzi, C., Hosoda, T., Bolli, R., Anversa, P., & Leri, A. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.05.025 · Cited by 103
Zheng, M., Cheng, H., Li, X., Zhang, J., Cui, L., Ouyang, K., Han, L., Zhao, T. S., Gu, Y., Dalton, N. D., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn400 · Cited by 100
Retro-orbital Injection in Adult Zebrafish
Pugach, E. K., Li, P., White, R. M., & Zon, L. I. (2009) · Journal of Visualized Experiments · doi:10.3791/1645 · Cited by 96
Gussak, I. B., CHAITMAN, B. R., Kopecky, S. L., & Nerbonne, J. M. (2000) · Journal of Electrocardiology · doi:10.1016/s0022-0736(00)80072-2 · Cited by 96
Hasinoff, B. B. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.12.032 · Cited by 95
Increased α2 Subunit–Associated AMPK Activity and PRKAG2 Cardiomyopathy
Ahmad, F., Arad, M., Musi, N., He, H., Wolf, C. M., Branco, D. M., Pérez‐Atayde, A. R., Stapleton, D., Bali, D. S., Xing, Y., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.550806 · Cited by 95
Meissner, K., Heydrich, B., Jedlitschky, G., zu Schwabedissen, H. E. M., Mosyagin, I. G., Dazert, P., Eckel, L., Vogelgesang, S., Warzok, R., Böhm, M., et al. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6750.2005 · Cited by 93
Kinases as targets in the treatment of solid tumors
Giamas, G., Man, Y. L., Hirner, H., Bischof, J., Kramer, K. M., Khan, K., Ahmed, S. S. L., Stebbing, J., & Knippschild, U. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.01.011 · Cited by 88
Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery
Braam, S. R., Passier, R., & Mummery, C. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.001 · Cited by 86
c-kit Is Required for Cardiomyocyte Terminal Differentiation
Li, M., Naqvi, N., Yahiro, E., Liu, K., Powell, P. C., Bradley, W. E., Martin, D. I. K., Graham, R. M., Dell’Italia, L. J., & Husain, A. (2008) · Circulation Research · doi:10.1161/circresaha.107.161737 · Cited by 86
TAO, R., Zhang, J., Vessey, D. A., Honbo, N., & Karliner, J. S. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.01.015 · Cited by 83
Pentassuglia, L., Timolati, F., Seifriz, F., Kaisaier, A., Suter, T. M., & Zuppinger, C. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.02.007 · Cited by 79
Stem Cell Factor Deficiency Is Vasculoprotective
Wang, C., Anderson, N. M., Li, S., Szmitko, P. E., Cherng, W., Fedak, P. W. M., Fazel, S. S., Li, R., Yau, T. M., Weisel, R. D., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000243210.79654.fd · Cited by 77
Oliveira, R. S. F., Ferreira, J. C. B., Gomes, E. R. D. M., da Paixão, N. A., Rolim, N. P. L., Medeiros, A., Guatimosim, S., & Brum, P. C. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.173948 · Cited by 76
ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice
Shi, J., Zhang, Y.-W., Yu, Y., Zhang, L., & Wei, L. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.08.008 · Cited by 71
Zhou, J., Lal, H., Chen, X., Shang, X., Song, J., Li, Y., Kerkelä, R., Doble, B. W., MacAulay, K., DeCaul, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41407 · Cited by 67
Self-citationLi, R. (1996) · Cardiovascular Research · doi:10.1016/0008-6363(96)00079-x · Cited by 66
VEGF kinase inhibitors: how do they cause hypertension?
Bhargava, P. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90502.2008 · Cited by 65
STAT3-Mediated Activation of Myocardial Capillary Growth
Hilfiker‐Kleiner, D., Limbourg, A., & Drexler, H. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.05.002 · Cited by 65
Taniike, M., Yamaguchi, O., Tsujimoto, I., Hikoso, S., Takeda, T., Nakai, A., Omiya, S., Mizote, I., Nakano, Y., Higuchi, Y., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.710434 · Cited by 65
O'Cochlain, D. F., Pérez-Terzic, C. M., Reyes, S., Kane, G. C., Behfar, A., Hodgson, D. M., Strommen, J. A., Liu, X., van den Broek, W. J. A. A., Wansink, D. G., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh266 · Cited by 63
Activation of AMPK is necessary for killing cancer cells and sparing cardiac cells
Shell, S. A., Lyass, L., Trusk, P. B., Pry, K. J., Wappel, R. L., & Bacus, S. S. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6016 · Cited by 59
Distinct organization of energy metabolism in HL-1 cardiac cell line and cardiomyocytes
Eimre, M., Paju, K., Pelloux, S., Béraud, N., Roosimaa, M., Kadaja, L., Puurand, M., Peet, N., Orlova, E., Remmelkoor, R., et al. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.03.019 · Cited by 56
Zsila, F., Fitos, I., Bencze, G., Kéri, G., & Őrfi, L. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709788682191 · Cited by 55
Olaharski, A. J., Gonzaludo, N., Bitter, H., GOLDSTEIN, D. M., Kirchner, S., Uppal, H., & Kolaja, K. L. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000446 · Cited by 54
Self-citationGoodwin, R. A., Ding, K., Seymour, L., LeMaître, A., Arnold, A., Shepherd, F. A., Dediu, M., Ciuleanu, T., Fenton, D. W., Zukin, M., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq221 · Cited by 44
Phospholamban phosphorylation by CaMKII under pathophysiological conditions
Vittone, L., Mundina-Weilenmann, C., & Mattiazzi, A. (2008) · Frontiers in bioscience · doi:10.2741/3131 · Cited by 43
Liang, H., Matzkies, M., Schunkert, H., Tang, M., Bonnemeier, H., Hescheler, J., & Reppel, M. (2010) · Cellular Physiology and Biochemistry · doi:10.1159/000303051 · Cited by 42
Rose, R. A., Kabir, M. G., & Backx, P. H. (2007) · Circulation Research · doi:10.1161/circresaha.107.158428 · Cited by 37
Thirunavukkarasu, M., Juhász, B., Zhan, L., Menon, V. P., Tósaki, Á., Otani, H., & Maulik, N. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.02.011 · Cited by 37
Bistola, V., Nikolopoulou, M., Derventzi, A., Kataki, A., Sfyras, N., Nikou, N., Toutouza, M. G., TOUTOUZAS, P. K., Stefanadis, C., & Konstadoulakis, M. M. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.058 · Cited by 28
Controllable Expansion of Primary Cardiomyocytes by Reversible Immortalization
Zhang, Y., Nuglozeh, E., Touré, F., Schmidt, A. M., & Vunjak‐Novakovic, G. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.057 · Cited by 27
Cyclin-dependent kinase 2 signaling regulates myocardial ischemia/reperfusion injury
Liem, D. A., Zhao, P., Angelis, E., Chan, S. S., Zhang, J., Wang, G., Berthet, C., Kaldis, P., Ping, P., & MacLellan, W. R. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.07.003 · Cited by 25
Apple, F. S. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2009.138727 · Cited by 20
Verkhivker, G. M. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm277 · Cited by 19
A cell-based sensor system for toxicity testing using multiwavelength fluorescence spectroscopy
Fritzsche, M., Fredriksson, J. M., Carlsson, M., & Mandenius, C. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.01.027 · Cited by 17
Mariani, S., Tornaghi, L., Sassone, M. C., Basciani, S., Buzzetti, R., Gambacorti-Passerini, C. B., Spera, G., & Gnessi, L. (2009) · Leukemia Research · doi:10.1016/j.leukres.2009.08.003 · Cited by 15
Genetic approaches for changing the heart and dissecting complex syndromes
Moga, M.-A., Nakamura, T., & Robbins, J. M. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.06.002 · Cited by 12
Cited by
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Zhang, S., Liu, X., Bawa-Khalfe, T., Lu, L.-S., Lyu, Y. L., Liu, L. F., & Yeh, E. T. H. (2012) · Nature Medicine · doi:10.1038/nm.2919 · Cited by 1,948
Kinase-targeted cancer therapies: progress, challenges and future directions
Bhullar, K. S., Lagarón, N. O., McGowan, E. M., Parmar, I., Jha, A., Hubbard, B. P., & Rupasinghe, H. P. V. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0804-2 · Cited by 1,245
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
Lin, A., Giuliano, C. J., Palladino, A., John, K. M., Abramowicz, C., Yuan, M. L., Sausville, E. L., Lukow, D. A., Liu, L., Chait, A. R., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw8412 · Cited by 754
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Bowes, J., Brown, A. J., Hamon, J., Jarolimek, W., Sridhar, A., Waldron, G., & Whitebread, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3845 · Cited by 748
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Curigliano, G., Cardinale, D., Dent, S., Criscitiello, C., Aseyev, O., Lenihan, D., & Cipolla, C. M. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21341 · Cited by 723
Metadata
- Authors
- Force, T., & Kolaja, K. L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-02
- Volume
- 10
- Issue
- 2
- Pages
- 111-126
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2070251374
- Cited by
- 363
- References
- 168
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.